Targeting fibrosis: Mechanisms and clinical trials

M Zhao, L Wang, M Wang, S Zhou, Y Lu… - Signal transduction and …, 2022 - nature.com
Fibrosis is characterized by the excessive extracellular matrix deposition due to
dysregulated wound and connective tissue repair response. Multiple organs can develop …

Mechanistic pathogenesis of endothelial dysfunction in diabetic nephropathy and retinopathy

J Yang, Z Liu - Frontiers in endocrinology, 2022 - frontiersin.org
Diabetic nephropathy (DN) and diabetic retinopathy (DR) are microvascular complications of
diabetes. Microvascular endothelial cells are thought to be the major targets of …

Targeting the PDGF/PDGFR signaling pathway for cancer therapy: A review

X Zou, XY Tang, ZY Qu, ZW Sun, CF Ji, YJ Li… - International Journal of …, 2022 - Elsevier
Platelet-derived growth factors (PDGFs) and PDGF receptors (PDGFRs) are expressed in a
variety of tumors. Activation of the PDGF/PDGFR signaling pathway is associated with …

Effect of doxorubicin plus olaratumab vs doxorubicin plus placebo on survival in patients with advanced soft tissue sarcomas: the ANNOUNCE randomized clinical trial

WD Tap, AJ Wagner, P Schöffski, J Martin-Broto… - Jama, 2020 - jamanetwork.com
Importance Patients with advanced soft tissue sarcoma (STS) have a median overall survival
of less than 2 years. In a phase 2 study, an overall survival benefit in this population was …

[HTML][HTML] Effect of stromal cells in tumor microenvironment on metastasis initiation

S Guo, CX Deng - International journal of biological sciences, 2018 - ncbi.nlm.nih.gov
The cellular environment where tumor cells reside is called the tumor microenvironment
(TME), which consists of borders, blood vessels, lymph vessels, extracellular matrix (ECM) …

[HTML][HTML] New insights about the PDGF/PDGFR signaling pathway as a promising target to develop cancer therapeutic strategies

P Pandey, F Khan, TK Upadhyay, M Seungjoon… - Biomedicine & …, 2023 - Elsevier
Numerous cancers express platelet-derived growth factors (PDGFs) and PDGF receptors
(PDGFRs). By directly stimulating tumour cells in an autocrine manner or by stimulating …

Cancer stem cells—key players in tumor relapse

M Marzagalli, F Fontana, M Raimondi, P Limonta - Cancers, 2021 - mdpi.com
Simple Summary Cancer is one of the hardest pathologies to fight, being one of the main
causes of death worldwide despite the constant development of novel therapeutic strategies …

Current status and prospects of targeted therapy for osteosarcoma

Z Hu, S Wen, Z Huo, Q Wang, J Zhao, Z Wang, Y Chen… - Cells, 2022 - mdpi.com
Osteosarcoma (OS) is a highly malignant tumor occurring in bone tissue with a high
propensity to metastasize, and its underlying mechanisms remain largely elusive. The OS …

Recent development of multi-target VEGFR-2 inhibitors for the cancer therapy

XJ Liu, HC Zhao, SJ Hou, HJ Zhang, L Cheng… - Bioorganic …, 2023 - Elsevier
Vascular epidermal growth factor receptor-2 (VEGFR-2), as an important tyrosine
transmembrane protein, plays an important role in regulating endothelial cell proliferation …

Role of cytokines and chemokines in angiogenesis in a tumor context

M Geindreau, M Bruchard, F Vegran - Cancers, 2022 - mdpi.com
Simple Summary Tumor growth in solid cancers requires adequate nutrient and oxygen
supply, provided by blood vessels created by angiogenesis. Numerous studies have …